ZECOTEK PHOTONICS HAT DEN DURCHBRUCH GESCHAFFT!!! - 500 Beiträge pro Seite

[Sonnenschein2007]

Agreement-in-Principle with Fujikura Ltd.
January 03, 2008
Zecotek and Fujikura Ltd. of Japan Reach Agreement-in-Principle on Partnership for Development, Manufacture and Distribution of Key Zecotek Products
Vancouver, BC – January 3, 2007 - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I) today announced that following the LOI signed in October and the recent visit by senior officials of Fujikura Ltd. to Zecotek’s Vancouver and Seattle facilities, both companies have reached an agreement-in-principle to form a partnership for the development, manufacture and sales of key Zecotek products, including Zecotek’s proprietary fiber lasers. In order to finalize the structural and operational details, both parties have agreed to extend the current LOI to January 31, 2008. Under the proposed agreement Fujikura will contribute, technical support and manufacturing know-how for certain products to be manufactured and distributed by Fujikura under the partnership.

“We are very pleased that following a thorough inspection of our facilities and our technologies, Fujikura officials came to a rapid decision to proceed with our proposed partnership,” said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek. “We see this as a very strong endorsement of both our technological leadership and our product development roadmap. Fujikura, with its technological awareness, manufacturing expertise, strong brand and global distribution network, will provide an outstanding partnership for Zecotek.”

Following meetings in Tokyo in November a delegation of senior Fujikura officials visited Zecotek’s Vancouver laboratories and inspected Zecotek’s 3D2D Display technology. The officials also visited laboratories at the University of British Columbia and University of Washington and inspected Zecotek’s joint Optical Coherence Tomography, Thin Film Laser and PET/MRI projects. At the conclusion of the visits, Fujikura and Zecotek reached an agreement-in-principle to form a partnership for the manufacture and sales of Zecotek products, including Zecotek’s proprietary fiber lasers.

“We are highly impressed with both Zecotek’s technological depth and the market potential of their product portfolio,” said a representative of Fujikura Ltd. “We look forward to working with Zecotek on not only their fiber lasers, but on many of their other products and technologies which complement and extend our current business lines.”

About Fujikura Limited
Fujikura is a leading manufacturer of world-class optical fiber communication cables. It is also active in optical components, optical instruments, new electronic and automotive components, and the development of new technologies. Fujikura Ltd commemorated the 120th anniversary of its founding in 2005. Today, the scope of its business has broadened beyond core cable products for the electrical power industry and plants, and encompasses the electronic equipment, auto and telecommunications industries. Fujikura relentlessly strives to create novel solutions through R&D and has delivered leading products, such as optical fibers and flexible print circuits. For more information, please visit www.fujikura.co.jp

About Zecotek
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I), is a photonics technology company developing high-performance crystals, photo detectors, lasers, optical imaging and 3D display technologies for commercial applications in the medical diagnostics and high-tech industries. Founded in 2003, the company operates three distinct divisions: imaging, lasers and 3D display, with labs located in Canada, USA, Singapore and Russia. Zecotek commercializes its novel, patented and patent-pending photonic technologies directly and through strategic alliances and joint ventures with multinational OEMs, distributors and other industry leaders. For more information, please visit www.zecotek.com.

This press release may contain forward-looking statements that are based on management’s expectations, estimates, projections and assumptions. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what may have been stated.

For additional information please contact:

Zecotek Photonics Inc., MICHAEL MINDER, CFO; VP Corporate Development, T: [phone]

Caliber Capital Partners, TIM MCNULTY, T: [phone], E: [e-mail]

Fujikura Ltd., DR. YONG-TSONG TAN, T: ([phone], E: [e-mail]

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release. If you would like to receive news from Zecotek in the future please visit the corporate website at www.zecotek.com.

[Sonnenschein2007]

Zecotek Medical Systems spekulativ kaufen (Der Aktionär)Kulmbach (aktiencheck.de AG) - Die Experten vom Anlegermagazin "Der Aktionär" raten die Aktie von Zecotek Medical Systems (ISIN CA9892131033/ WKN A0JKHL) spekulativ zu kaufen.
Das kanadische Unternehmen habe eigenen Bekundungen nach, einen sehr hoch auflösenden 3D-Bildschirm entwickelt. Dieser solle im November der Öffentlichkeit präsentiert werden. Bei Produktion und Vertrieb könnte ein bekanntes japanisches Elektronikunternehmen helfen, welches im März 2007 eine entsprechende Erklärung (Letter of Intent) mit Zecotek unterzeichnet habe.

Neben dem 3D-Bildschirm habe Zecotek noch zwei weitere technologische Innovationen zu bieten, die gemeinsam die Positronen-Emissions-Tomographie (PET) einen großen Schritt nach vorne bringen könnten. Die PET sei ein bildgebendes Verfahren der Nuklearmedizin. Es erzeuge Schnittbilder von lebenden Organismen. Mit ihr würden sich Krankheiten wie Krebs, Alzheimer und Parkinson diagnostizieren lassen. Die PET-Geräte seien mit Kristallen ausgestatten, die für die Lenkung des Lichts verantwortlich seien. Dieses werde dann von Photodetektoren aufgefangen. Die von Zecotek entwickelten Kristalle und Photodetektoren würden nicht nur klarere und hellere Bilder liefern, sie würden auch die Herstellungskosten für ein PET-Gerät um bis zu 40 Prozent senken. Nach Ansicht der Wertpapierexperten könnte sich jedes Produkt von Zecotek zu einem Blockbuster entwickeln.

Die Experten von "Der Aktionär" raten die Zecotek Medical Systems-Aktie spekulativ zu kaufen. Das Kursziel sehe man bei 1,60 EUR. (Ausgabe 40)
(26.09.2007/ac/a/a) Analyse-Datum: 26.09.2007

[Sonnenschein2007]

The History of Zecotek
We excel in the innovation and commercialization of key enabling technology, subsystems, and components for medical and industrial imaging, computer generated and real time 3D visualization as well as lasers for bio-pharmaceutical and a wide range of scientific research and industrial applications.

Zecotek Photonics Inc. is a public company founded by Dr. A. F. Zerrouk in December 2004, in an effort to fund the final phase of research and development of an array of photonics technologies and their transfer to manufacturing and commercialization. Dr. Zerrouk brings to the company a wealth of knowledge and experience in the photonics industries. In 1989, he established the first foreign partnered, private, business oriented photonics research Lab in the Ex-Soviet Union ( Novosibirsk, Siberia). He duplicated the same model in three prestigious research institutes in Moscow. Dr. Zerrouk has acted as a technology transfer advisor, working closely with the Ministry of Science and Technology during the transition period to the Russian federation. He worked on Research and Development strategies for the new economy with prominent members of the Russian Academy of Science and coordinated many government projects in joint relations between Russia and countries like China, Germany, USA, Malaysia, and Saudi Arabia. Dr. Zerrouk was Chairman and CEO of various companies in Europe and Asia. He has held research and faculty positions at various centers: the Clarendon Laboratory, University of Oxford, England, (Atomic & Laser physics); Siberian Academy of Sciences (TOKAMAK and Laser fusion research); the Institute of Thermal Processes, Moscow (high-power gas dynamic lasers) and the Institute of General Physics, Moscow.

In December 2004, Zecotek's new, wholly owned subsidiary, Zecotek Crystals Inc. (“ Crystals”), acquired from Zecotek Holdings Inc. (“Holdings”) the intellectual property and know-how, associated with a new and proprietary scintillation crystal ("LFS") that emits blue light and that is a key component in the design of whole body positron emission tomograph ("PET") scanners.

In early 2006, the senior management team determined it could derive superior returns and increased shareholder value through the integration of its various technologies into higher value-added components and the selective production of finished product. Following this decision, several sites for the establishment of manufacturing and commercialization facilities were evaluated, with Singapore and Malaysia eventually chosen.

In April 2006, Zecotek incorporated a new, wholly owned subsidiary in Singapore. For strategic, operational and financial efficiencies the Singapore operations have been organized into three separate and distinct divisions; Zecotek Imaging Systems, Zecotek Display Sytems and Zecotek Laser Systems. The Singapore operations will continue to be supported by Zecotek related laboratories in Russia and Canada, as well as collaboration partners in the U.S and Canada, and by project management and market development from North America and Europe - much of which will also qualify for grant support from Singapore.

These new technologies include:


a real time auto-stereoscopic 3D display;

various solid state and fiber laser technologies, including a solid state laser for bio-instrumentation, and a thin film waveguide micro laser technology, the latter being currently in development jointly with UBC;

enabling technologies for combined PET-MRI machines;

a new scintillation material for medical imaging to eventually serve as a successor material to the LFS;

a solid state analog to the existing photomultiplier tube;

the RFO crystal, aimed at substituting the present YAG crystal for various laser applications;
a light source for optical coherence tomography, in development in conjunction with UBC.
Zecotek Photonics Inc. is a Canadian public company trading on the TSX Venture Exchange under the symbol “ZMS.V”. On April 20, 2006, the Company’s shares began trading on the Frankfurt Stock Exchange under the trading symbol - W1I.F.




Copyright © 2005–2007 Zecotek Photonics Inc. – All Rights Reserved
http://www.zecotek.com – [e-mail]

[Sonnenschein2007]

Antwort auf Beitrag Nr.: 32.922.939 von Sonnenschein2007 am 03.01.08 10:21:09

1,92 CAD !!!

[Sonnenschein2007]

Antwort auf Beitrag Nr.: 32.922.939 von Sonnenschein2007 am 03.01.08 10:21:09

+18,52 %

[Piatti]

...so sieht es aus, wenn ein Alleinunterhalter mal zu Wort kommen möchte!